Arca Biopharma Stock Market Value
| ABIO Stock | USD 3.25 0.04 1.25% |
| Symbol | ARCA |
ARCA Biopharma Price To Book Ratio
Is ARCA Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ARCA Biopharma. If investors know ARCA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ARCA Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Return On Assets (0.11) | Return On Equity (0.14) |
The market value of ARCA Biopharma is measured differently than its book value, which is the value of ARCA that is recorded on the company's balance sheet. Investors also form their own opinion of ARCA Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ARCA Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARCA Biopharma's market value can be influenced by many factors that don't directly affect ARCA Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARCA Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARCA Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARCA Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ARCA Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ARCA Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ARCA Biopharma.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in ARCA Biopharma on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding ARCA Biopharma or generate 0.0% return on investment in ARCA Biopharma over 30 days. ARCA Biopharma is related to or competes with Pmv PharmaceuticalsI. ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted thera... More
ARCA Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ARCA Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ARCA Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.06 | |||
| Information Ratio | 0.1251 | |||
| Maximum Drawdown | 95.29 | |||
| Value At Risk | (3.05) | |||
| Potential Upside | 3.14 |
ARCA Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ARCA Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ARCA Biopharma's standard deviation. In reality, there are many statistical measures that can use ARCA Biopharma historical prices to predict the future ARCA Biopharma's volatility.| Risk Adjusted Performance | 0.0905 | |||
| Jensen Alpha | 1.37 | |||
| Total Risk Alpha | 0.3985 | |||
| Sortino Ratio | 0.6817 | |||
| Treynor Ratio | 0.9406 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ARCA Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ARCA Biopharma Backtested Returns
ARCA Biopharma is dangerous given 3 months investment horizon. ARCA Biopharma retains Efficiency (Sharpe Ratio) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.54% are justified by taking the suggested risk. Use ARCA Biopharma market risk adjusted performance of 0.9506, and Coefficient Of Variation of 762.18 to evaluate company specific risk that cannot be diversified away. ARCA Biopharma holds a performance score of 10 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 1.55, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ARCA Biopharma will likely underperform. Use ARCA Biopharma value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to analyze future returns on ARCA Biopharma.
Auto-correlation | 0.34 |
Below average predictability
ARCA Biopharma has below average predictability. Overlapping area represents the amount of predictability between ARCA Biopharma time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ARCA Biopharma price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current ARCA Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | 0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
ARCA Biopharma lagged returns against current returns
Autocorrelation, which is ARCA Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ARCA Biopharma's stock expected returns. We can calculate the autocorrelation of ARCA Biopharma returns to help us make a trade decision. For example, suppose you find that ARCA Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ARCA Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ARCA Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ARCA Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ARCA Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
ARCA Biopharma Lagged Returns
When evaluating ARCA Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ARCA Biopharma stock have on its future price. ARCA Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ARCA Biopharma autocorrelation shows the relationship between ARCA Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in ARCA Biopharma.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ARCA Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ARCA Biopharma's short interest history, or implied volatility extrapolated from ARCA Biopharma options trading.
Pair Trading with ARCA Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ARCA Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARCA Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving against ARCA Stock
| 0.85 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.68 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
| 0.48 | KZR | Kezar Life Sciences Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to ARCA Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ARCA Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ARCA Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ARCA Biopharma to buy it.
The correlation of ARCA Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ARCA Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ARCA Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ARCA Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out ARCA Biopharma Correlation, ARCA Biopharma Volatility and ARCA Biopharma Alpha and Beta module to complement your research on ARCA Biopharma. To learn how to invest in ARCA Stock, please use our How to Invest in ARCA Biopharma guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for ARCA Stock analysis
When running ARCA Biopharma's price analysis, check to measure ARCA Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARCA Biopharma is operating at the current time. Most of ARCA Biopharma's value examination focuses on studying past and present price action to predict the probability of ARCA Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ARCA Biopharma's price. Additionally, you may evaluate how the addition of ARCA Biopharma to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
ARCA Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.